Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2003-12-31
2008-10-21
Wilson, James (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S081000, C514S257000, C514S266200, C514S267000, C544S244000, C544S250000, C544S284000, C544S285000
Reexamination Certificate
active
07439249
ABSTRACT:
The present invention relates to compounds that inhibit phosphatases, compositions thereof, and methods of using those compounds and compositions for treating diseases.
REFERENCES:
patent: 5234928 (1993-08-01), Fujimori et al.
patent: 0 456 835 (1991-11-01), None
patent: WO 95/15963 (1995-06-01), None
patent: WO 98/18781 (1998-05-01), None
patent: WO 98/56770 (1998-12-01), None
Malamas, et al., “Quinazolineacetic Acids and Related Analogues as Aldose Reductase Inhibitors”, J. Med. Chem., vol. 34, No. 4, pp. 1492-1503 (1991).
Gordeev, et al., “A General and Efficient Solid Phase Synthesis of Quinazoline-2,4-diones.”, Tetrahedron Letters, Vo. 38, No. 10, pp. 1729-1732 (1997).
Blake James F.
Buckmelter Alexandre J.
Hunt Kevin W.
Miknis Gregory F.
Saunders Jeffrey O.
Badia Michael C.
Truong Tamthom N
Vertex Pharmaceuticals Incorporated
Wilson James
LandOfFree
Inhibitors of phosphatases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of phosphatases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of phosphatases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4013639